Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
E2F7
|
ENSG00000165891.11 | E2F transcription factor 7 |
E2F1
|
ENSG00000101412.9 | E2F transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
E2F7 | hg19_v2_chr12_-_77459306_77459365 | 0.34 | 6.0e-02 | Click! |
E2F1 | hg19_v2_chr20_-_32274179_32274213 | 0.18 | 3.3e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.7 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
1.0 | 3.1 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.9 | 2.8 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
0.9 | 2.6 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.8 | 3.1 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.8 | 2.3 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.6 | 2.6 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.6 | 1.9 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.6 | 1.7 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.6 | 1.7 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.5 | 1.5 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.5 | 1.5 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.5 | 1.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.4 | 1.3 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.4 | 2.8 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.4 | 1.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 1.6 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.4 | 1.2 | GO:0048627 | myoblast development(GO:0048627) |
0.4 | 1.1 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.4 | 1.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.4 | 2.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.4 | 1.1 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.3 | 1.0 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.3 | 2.0 | GO:2000683 | regulation of cellular response to X-ray(GO:2000683) |
0.3 | 2.0 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.3 | 1.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 1.3 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.3 | 1.0 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
0.3 | 1.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 1.2 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.3 | 3.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 1.2 | GO:0044691 | tooth eruption(GO:0044691) |
0.3 | 0.6 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
0.3 | 0.8 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
0.3 | 0.8 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 1.1 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.3 | 1.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 0.5 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.3 | 1.1 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 1.0 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.3 | 2.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 0.3 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
0.3 | 0.8 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.3 | 1.5 | GO:0030421 | defecation(GO:0030421) |
0.3 | 1.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.3 | 0.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 0.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 1.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 1.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 1.8 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.2 | 2.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 0.9 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.2 | 0.7 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.2 | 0.6 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.2 | 1.3 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 0.6 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.2 | 0.8 | GO:0032752 | response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
0.2 | 2.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 1.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 1.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.6 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.2 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 1.5 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.2 | 0.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 2.7 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 1.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.9 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.2 | 1.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.0 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.2 | 1.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 1.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 1.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 1.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.7 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.2 | 0.3 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.2 | 0.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 1.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 1.1 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.2 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.6 | GO:1903566 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
0.2 | 0.3 | GO:0071103 | DNA conformation change(GO:0071103) |
0.2 | 1.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.3 | GO:0032796 | uropod organization(GO:0032796) |
0.2 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 1.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 0.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 0.6 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.1 | 1.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.6 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.1 | 0.3 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.6 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 1.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.6 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.1 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.4 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.4 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.1 | 0.4 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.1 | 1.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.7 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.4 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.1 | 0.9 | GO:0060356 | leucine import(GO:0060356) |
0.1 | 0.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 0.1 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.1 | 0.5 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 1.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 1.5 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 2.6 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.5 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.1 | 0.4 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.1 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.6 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.5 | GO:0060032 | notochord regression(GO:0060032) |
0.1 | 0.4 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.5 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 1.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 2.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.8 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.1 | 0.3 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.1 | 0.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 0.4 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.9 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.1 | 1.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 1.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 4.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 2.0 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 1.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.8 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 1.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 2.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.2 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.1 | 2.5 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 1.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 3.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 3.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.4 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.6 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 1.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.4 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 0.8 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 1.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 1.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.1 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.1 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 1.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 1.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.3 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.9 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.1 | 0.3 | GO:1990868 | beta selection(GO:0043366) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.1 | 0.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 0.9 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 2.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 0.4 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.1 | 0.3 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.8 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 1.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.6 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.1 | 0.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 0.3 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.8 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.5 | GO:2000110 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.7 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.2 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.6 | GO:0010266 | response to vitamin B1(GO:0010266) |
0.1 | 0.4 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 0.1 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.1 | 1.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0090298 | base-excision repair, DNA ligation(GO:0006288) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 | 0.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 2.0 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 1.9 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.1 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.4 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.1 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 1.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 1.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 1.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 1.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.2 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 0.3 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.2 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 0.4 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 1.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.3 | GO:0009956 | radial pattern formation(GO:0009956) |
0.1 | 0.4 | GO:0046469 | plasma lipoprotein particle oxidation(GO:0034441) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.3 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.1 | 1.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.9 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.2 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
0.1 | 1.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.4 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.1 | 0.3 | GO:0003289 | septum secundum development(GO:0003285) atrial septum primum morphogenesis(GO:0003289) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.1 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 | 0.4 | GO:2000784 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 1.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 1.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 2.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 0.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.3 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 1.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.4 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 0.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.1 | 0.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.1 | 0.5 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 1.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 1.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.3 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.1 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.0 | 7.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.0 | 0.7 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.0 | 0.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.0 | 0.3 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.0 | 0.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.0 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.7 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.1 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.0 | 0.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 1.2 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.2 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.0 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.3 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.0 | 1.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.0 | 0.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.1 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.0 | 0.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.0 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.0 | 0.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.2 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 0.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.2 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.0 | 0.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 0.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 1.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.0 | 0.5 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.3 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.0 | 0.3 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.0 | 0.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.0 | 0.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.3 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 4.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.1 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.0 | 0.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.2 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.0 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 1.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.0 | 1.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 1.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.7 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.0 | 0.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 1.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 1.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.2 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.0 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.5 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.1 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.0 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 1.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 0.0 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.5 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.0 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.5 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.0 | 1.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
0.0 | 3.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.1 | GO:1904438 | positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
0.0 | 1.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 2.5 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.1 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.0 | 0.1 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 2.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 1.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 1.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.0 | 0.2 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.0 | 0.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.0 | 0.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.0 | 0.3 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.3 | GO:0001822 | kidney development(GO:0001822) |
0.0 | 1.3 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 1.2 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.4 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 1.6 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.0 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.0 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.3 | GO:0046324 | regulation of glucose transport(GO:0010827) regulation of glucose import(GO:0046324) |
0.0 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) posttranscriptional gene silencing by RNA(GO:0035194) |
0.0 | 0.5 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.0 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 1.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 2.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 2.0 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.4 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.0 | 0.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0061441 | renal artery morphogenesis(GO:0061441) kidney smooth muscle tissue development(GO:0072194) |
0.0 | 1.0 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 1.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0042335 | cuticle development(GO:0042335) |
0.0 | 0.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.0 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0071529 | cementum mineralization(GO:0071529) |
0.0 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 1.7 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 0.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.0 | 0.1 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.5 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.0 | 0.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.0 | 0.1 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.0 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.4 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.3 | GO:0000732 | strand displacement(GO:0000732) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.5 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 1.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:1902228 | mammary gland fat development(GO:0060611) mammary duct terminal end bud growth(GO:0060763) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
0.0 | 0.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.0 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.0 | 0.8 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.0 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 1.9 | GO:0019083 | viral transcription(GO:0019083) |
0.0 | 0.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.1 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.1 | GO:0051665 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.0 | 0.2 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 0.2 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.4 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.6 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.5 | 1.5 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.4 | 1.2 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.4 | 0.4 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.3 | 4.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 1.6 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.3 | 1.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 2.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.6 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.3 | 2.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 5.0 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 2.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 3.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 0.7 | GO:0008623 | CHRAC(GO:0008623) |
0.2 | 2.3 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 1.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 4.9 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 1.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 2.3 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 1.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 2.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 2.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.4 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 3.9 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.6 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.2 | 2.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.5 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.2 | 1.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 3.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 0.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.9 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 0.7 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.1 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 1.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 2.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 1.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 2.1 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 1.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 3.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 5.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 1.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 1.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.6 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.1 | 1.3 | GO:0032059 | bleb(GO:0032059) |
0.1 | 1.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.6 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.4 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.1 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 2.9 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 2.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.1 | 1.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.5 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 1.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.1 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.4 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 4.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 1.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 5.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 1.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 1.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 2.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 1.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 1.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 2.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.9 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 5.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 1.8 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 7.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.7 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 1.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 4.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.8 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.1 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 4.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 3.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 2.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 2.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 1.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 1.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 12.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 3.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0002133 | polycystin complex(GO:0002133) |
0.0 | 2.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.7 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.0 | 4.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 2.1 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 12.7 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.4 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.0 | 3.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.0 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.0 | 1.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 1.1 | GO:0034702 | ion channel complex(GO:0034702) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.8 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 1.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.2 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 1.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 1.6 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.8 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.7 | 6.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.5 | 2.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.4 | 1.3 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.4 | 1.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 1.5 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.4 | 1.1 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.3 | 2.7 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 2.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.2 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.3 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 2.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.8 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 1.1 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.3 | 0.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.3 | 1.0 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.3 | 1.3 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.3 | 5.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.9 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 1.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 0.7 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.2 | 2.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.8 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.2 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.2 | 1.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 2.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 1.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 1.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 1.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 1.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.9 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 0.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 1.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 1.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 1.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.7 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.1 | 1.3 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.1 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 4.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 3.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 1.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 2.8 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.3 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.1 | 0.3 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.1 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.1 | 2.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.9 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.4 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 0.9 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 1.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.7 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 0.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 1.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 2.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.3 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 0.5 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.3 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.1 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.7 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.3 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.1 | 0.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 4.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.5 | GO:0045118 | azole transporter activity(GO:0045118) |
0.1 | 1.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 2.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 2.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 1.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.7 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 0.3 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 9.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 0.2 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.1 | 0.2 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.1 | 0.3 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.1 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.6 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.3 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 2.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.1 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 3.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 1.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 6.8 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.1 | 1.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.0 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 1.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.0 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 1.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 1.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.2 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.0 | 1.0 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 3.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 1.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 3.1 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 2.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.9 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 3.9 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) RNA-dependent ATPase activity(GO:0008186) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.0 | 3.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 1.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.0 | 0.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.8 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.3 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 7.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 1.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 2.4 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 1.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.0 | 2.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 3.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 14.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.1 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.0 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 1.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 1.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
0.0 | 0.1 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.0 | 4.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 3.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 1.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 2.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 3.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 1.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 1.4 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 1.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 1.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 1.7 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 1.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 4.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 3.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 1.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 3.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 4.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 4.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 2.1 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.0 | 0.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.1 | GO:0004335 | galactokinase activity(GO:0004335) |
0.0 | 0.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 1.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.0 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 2.2 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 12.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 7.6 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 12.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 2.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 3.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 2.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 3.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 3.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 1.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 2.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 2.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 3.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 2.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 3.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 1.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 4.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.3 | 6.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 5.6 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 1.2 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.2 | 4.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 3.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 3.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 2.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 3.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 5.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 2.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 3.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.9 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 12.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 4.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 3.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 3.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 9.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 4.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 3.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 1.3 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 1.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 4.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 2.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 2.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 2.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 2.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 1.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 2.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 1.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 3.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 2.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |